Skip to main content
Clinical Trials/CTRI/2023/10/058703
CTRI/2023/10/058703Not yet recruitingPhase 4

Evaluation of Medication Adherence in Geriatric Patients with Type 2 Diabetes through Real time Monitoring & Clinical Pharmacological Reconciliation: A Multi-Centre Randomized Controlled Trial

Not provided3 sites in 1 country360 target enrollmentStarted: October 20, 2023Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Enrollment
360
Locations
3
Primary Endpoint
Medication adherence rate (pill counting method)

Study Overview

Brief Summary

Incorporatingmedication adherence devices and/or clinical pharmacological interventions inaddition to standard of care may lead to improved medication adherence andbetter glycemic control in elderly patients with T2DM on oral anti-diabeticmedications. With this in view, the present study aims to evaluate the effect of medication adherence tooland clinical pharmacological reconciliation in improving medication adherenceamong geriatric patients with type 2 diabetes mellitus (T2DM) attending theOPD.

Study Design

Study Type
Interventional
Allocation
Random Number Table
Masking
Open Label

Eligibility Criteria

Ages
60.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients with T2DM on oral antidiabetic agents having a having a medication adherence rate of less than 80% in the last 12 months.

Exclusion Criteria

  • Those patient with T2DM on oral antidiabetic agents having a medication adherence rate of more than 80% in the last 12 months.

Outcomes

Primary Outcomes

Medication adherence rate (pill counting method)

Time Frame: Every three months, for a period of one year

Secondary Outcomes

  • Adverse Drug Reactions(Every three months, for a period of one year)

Investigators

Sponsor
Not provided

Study Sites (3)

Loading locations...

Similar Trials

Medication Adherence in Geriatrics with... | Clinical Trial